Michael John Sumner - 28 Feb 2024 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Medical Officer
Signature: /s/ Michael John Sumner
Issuer symbol: INO
Transactions as of: 28 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 28 Feb 2024, 17:03:33 UTC
Previous filing: 03 Jul 2023
Next filing: 16 May 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Common Stock Option	Award	$0	+18,750		$0.000000	18,750	28 Feb 2024	Common Stock	18,750	$8.46	Direct	F1
transaction	INO	Restricted Stock Unit	Award	$0	+15,029		$0.000000	15,029	28 Feb 2024	Common Stock	15,029		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Content

The vesting schedule for the 18,750 options is as follows: 4,688 shares vested on February 28, 2024; 4,688 shares will vest on February 28, 2025; 4,687 shares will vest on February 28, 2026; and 4,687 shares will vest on February 28, 2027.

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units is as follows: 5,010 shares will vest on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.